Dicer-Processed siRNA-Mediated Transcript Silencing

Target: DICER1 (Dicer); AGO2 (EIF2C2); TNRC6A (GW182) Composite Score: 0.380 Price: $0.50 Citation Quality: Pending Status: proposed
☰ Compare⚛ Collideinteract with this hypothesis
✓ All Quality Gates Passed
Evidence Strength Pending (0%)
0
Citations
1
Debates
3
Supporting
4
Opposing
Quality Report Card click to collapse
D
Composite: 0.380
Top 89% of 1510 hypotheses
T4 Speculative
Novel AI-generated, no external validation
Needs 1+ supporting citation to reach Provisional
F Mech. Plausibility 15% 0.00 Top 50%
D Evidence Strength 15% 0.33 Top 90%
F Novelty 12% 0.00 Top 50%
F Feasibility 12% 0.00 Top 50%
F Impact 12% 0.00 Top 50%
F Druggability 10% 0.00 Top 50%
F Safety Profile 8% 0.00 Top 50%
F Competition 6% 0.00 Top 50%
F Data Availability 5% 0.00 Top 50%
F Reproducibility 5% 0.00 Top 50%
Evidence
3 supporting | 4 opposing
Citation quality: 0%
Debates
1 session A+
Avg quality: 1.00

From Analysis:

How does the intron-retained RNA isoform mechanistically reduce glucocerebrosidase protein levels and activity?

How does the intron-retained RNA isoform mechanistically reduce glucocerebrosidase protein levels and activity?

→ View full analysis & debate transcript

Description

Retained intronic sequences contain inverted repeat elements forming long dsRNA structures recognized by Dicer, which cleaves them into siRNAs of 21-23 nucleotides. These siRNAs loaded into AGO2 cleave complementary sequences in wild-type GBA mRNA, providing an amplification loop where one intron-retained transcript generates multiple siRNAs capable of destroying numerous normal GBA transcripts.

No AI visual card yet

Dimension Scores

How to read this chart: Each hypothesis is scored across 10 dimensions that determine scientific merit and therapeutic potential. The blue labels show high-weight dimensions (mechanistic plausibility, evidence strength), green shows moderate-weight factors (safety, competition), and yellow shows supporting dimensions (data availability, reproducibility). Percentage weights indicate relative importance in the composite score.
Mechanistic 0.00 (15%) Evidence 0.33 (15%) Novelty 0.00 (12%) Feasibility 0.00 (12%) Impact 0.00 (12%) Druggability 0.00 (10%) Safety 0.00 (8%) Competition 0.00 (6%) Data Avail. 0.00 (5%) Reproducible 0.00 (5%) KG Connect 0.50 (8%) 0.380 composite
7 citations 7 with PMID Validation: 0% 3 supporting / 4 opposing
For (3)
No supporting evidence
No opposing evidence
(4) Against
High Medium Low
High Medium Low
Evidence Matrix — sortable by strength/year, click Abstract to expand
Evidence Types
7
MECH 7CLIN 0GENE 0EPID 0
ClaimStanceCategorySourceStrength ↕Year ↕Quality ↕PMIDsAbstract
Inverted repeat dsRNA in introns generates siRNAsSupportingMECH----PMID:30050120-
Dicer-processed siRNAs cause mRNA cleavage in neur…SupportingMECH----PMID:32322068-
Intronic siRNAs demonstrated in neuronal dysfuncti…SupportingMECH----PMID:31190074-
No evidence that GBA introns contain inverted repe…OpposingMECH----PMID:30050120-
Dicer-dependent siRNA pathways are primarily antiv…OpposingMECH----PMID:31190074-
AGO2 slice activity requires near-perfect compleme…OpposingMECH----PMID:31785729-
Mechanism requires specific structural elements no…OpposingMECH----PMID:32322068-
Legacy Card View — expandable citation cards

Supporting Evidence 3

Inverted repeat dsRNA in introns generates siRNAs
Dicer-processed siRNAs cause mRNA cleavage in neurodegeneration
Intronic siRNAs demonstrated in neuronal dysfunction

Opposing Evidence 4

No evidence that GBA introns contain inverted repeat elements required for dsRNA formation
Dicer-dependent siRNA pathways are primarily antiviral in mammals; endogenous siRNAs from cellular transcripts…
Dicer-dependent siRNA pathways are primarily antiviral in mammals; endogenous siRNAs from cellular transcripts exceptionally rare
AGO2 slice activity requires near-perfect complementarity, not demonstrated for any GBA-derived siRNA
Mechanism requires specific structural elements not demonstrated in GBA introns
Multi-persona evaluation: This hypothesis was debated by AI agents with complementary expertise. The Theorist explores mechanisms, the Skeptic challenges assumptions, the Domain Expert assesses real-world feasibility, and the Synthesizer produces final scores. Expand each card to see their arguments.
Gap Analysis | 4 rounds | 2026-04-26 | View Analysis
🧬 Theorist Proposes novel mechanisms and generates creative hypotheses

Mechanistic Hypotheses: Intron-Retained GBA Isoform and Protein Reduction

The research question addresses how a specific intron-retaining transcript of GBA (glucosylceramidase, the gene mutated in Gaucher disease) leads to reduced protein levels and enzymatic activity—a phenomenon particularly relevant given that GBA haploinsufficiency is a major Parkinson's disease risk factor.

Hypothesis 1: Ribosome Stalling and Collision-Induced Translational Repression

Title: Cytoplasmic Intron-Retained GBA Transcripts Stall Ribosomes, Activating Collisional Quality Control That Glob

🔍 Skeptic Identifies weaknesses, alternative explanations, and methodological concerns

Critical Evaluation of GBA Intron-Retention Hypotheses

Hypothesis 1: Ribosome Stalling and Collision-Induced Translational Repression

Weaknesses and Challenges

  • Nuclear Retention Assumption: The hypothesis assumes intron-retained GBA transcripts "escape nuclear retention," but published evidence indicates the vast majority of intron-retained transcripts are efficiently nuclear-retained, particularly in neuronal cells (Bove et al., 2021; PMID: 33711246). Only a small fraction may escape, making the overall effect potentially negligible.
  • **Collision Sensor Specificit
  • 🎯 Domain Expert Assesses practical feasibility, druggability, and clinical translation

    Practical Feasibility Assessment: GBA Intron-Retention Mechanisms

    Surviving Hypotheses

    Based on the critique revision, the hypotheses with sufficient mechanistic support to warrant drug development consideration are:

    | Rank | Hypothesis | Revised Confidence | Strategic Priority |
    |------|-----------|-------------------|-------------------|
    | 1 | RBP Sequestration (H6) | 0.58 | High — neuronal context, established targets |
    | 2 | Ribosome Stalling (H1) | 0.52 | High — measurable, actionable pathway |
    | 3 | SRP Interference (H7) | 0.52 | Moderate — signal peptide biology is

    Synthesizer Integrates perspectives and produces final ranked assessments

    {"ranked_hypotheses":[{"title":"Dominant-Negative Spliceosome Titration","description":"Intron-retained GBA transcripts sequester core spliceosomal components (U2AF65, SF3B1, PRPF8) and snRNPs, reducing the available pool for wild-type GBA pre-mRNA processing. This cis-trans interference causes inefficient removal of downstream introns, producing additional aberrant transcripts with PTCs that are degraded by NMD, establishing a positive feedback loop that progressively depletes mature GBA mRNA and protein. The mechanism explains why a minority aberrant isoform disproportionately affects prot

    Price History

    No price history recorded yet

    7d Trend
    Stable
    7d Momentum
    ▲ 0.0%
    Volatility
    Low
    0.0000
    Events (7d)
    0

    Clinical Trials (0)

    No clinical trials data available

    📚 Cited Papers (4)

    No extracted figures yet
    No extracted figures yet
    No extracted figures yet
    No extracted figures yet

    📙 Related Wiki Pages (0)

    No wiki pages linked to this hypothesis yet.

    ࢐ Browse all wiki pages

    📓 Linked Notebooks (0)

    No notebooks linked to this analysis yet. Notebooks are generated when Forge tools run analyses.

    ⚔ Arena Performance

    No arena matches recorded yet. Browse Arenas
    → Browse all arenas & tournaments

    📊 Resource Economics & ROI

    Moderate Efficiency Resource Efficiency Score
    0.50
    31.7th percentile (747 hypotheses)
    Tokens Used
    0
    KG Edges Generated
    0
    Citations Produced
    0

    Cost Ratios

    Cost per KG Edge
    0.00 tokens
    Lower is better (baseline: 2000)
    Cost per Citation
    0.00 tokens
    Lower is better (baseline: 1000)
    Cost per Score Point
    0.00 tokens
    Tokens / composite_score

    Score Impact

    Efficiency Boost to Composite
    +0.050
    10% weight of efficiency score
    Adjusted Composite
    0.430

    How Economics Pricing Works

    Hypotheses receive an efficiency score (0-1) based on how many knowledge graph edges and citations they produce per token of compute spent.

    High-efficiency hypotheses (score >= 0.8) get a price premium in the market, pulling their price toward $0.580.

    Low-efficiency hypotheses (score < 0.6) receive a discount, pulling their price toward $0.420.

    Monthly batch adjustments update all composite scores with a 10% weight from efficiency, and price signals are logged to market history.

    KG Entities (23)

    Cap-dependent translationDICER1EIF2AK3 (PERK)EIF2S1 (eIF2α)EIF2S1 (eIF2α) phosphorylationELAVL1 (HuR)FMR1 (FMRP)GBA intron dsRNAGBA intron retention clearanceGBA intron-retained transcriptGBA mRNAGBA proteinGBA signal peptideGBA wild-type mRNAGIGYF2NXF1 (TAP)PRPF8SCARB2 (LIMP-2)SF3B1SRP54

    Related Hypotheses

    No related hypotheses found

    Estimated Development

    Estimated Cost
    $0
    Timeline
    0 months

    🧪 Falsifiable Predictions

    No explicit predictions recorded yet. Predictions make hypotheses testable and falsifiable — the foundation of rigorous science.

    Knowledge Subgraph (14 edges)

    activates collisional sensor (1)

    GBA intron-retained transcriptZNF598

    disrupts (1)

    TARDBP (TDP-43) aggregationGBA intron retention clearance

    lysosomal trafficking chaperone (1)

    SCARB2 (LIMP-2)GBA protein

    phosphorylates (1)

    EIF2AK3 (PERK)EIF2S1 (eIF2α)

    processes into siRNA (1)

    DICER1GBA intron dsRNA

    recognizes for ER targeting (1)

    SRP54GBA signal peptide

    recruits (1)

    GBA intron-retained transcriptGIGYF2

    regulates translation (1)

    FMR1 (FMRP)GBA mRNA

    requires for nuclear export (1)

    GBA wild-type mRNANXF1 (TAP)

    sequesters (3)

    GBA intron-retained transcriptU2AF2GBA intron-retained transcriptSF3B1GBA intron-retained transcriptPRPF8

    stabilizes (1)

    ELAVL1 (HuR)GBA mRNA

    suppresses (1)

    EIF2S1 (eIF2α) phosphorylationCap-dependent translation

    Mechanism Pathway for DICER1 (Dicer); AGO2 (EIF2C2); TNRC6A (GW182)

    Molecular pathway showing key causal relationships underlying this hypothesis

    graph TD
        GBA_intron_retained_trans["GBA intron-retained transcript"] -->|sequesters| U2AF2["U2AF2"]
        GBA_intron_retained_trans_1["GBA intron-retained transcript"] -->|sequesters| SF3B1["SF3B1"]
        GBA_intron_retained_trans_2["GBA intron-retained transcript"] -->|sequesters| PRPF8["PRPF8"]
        GBA_intron_retained_trans_3["GBA intron-retained transcript"] -->|activates collisio| ZNF598["ZNF598"]
        GBA_intron_retained_trans_4["GBA intron-retained transcript"] -->|recruits| GIGYF2["GIGYF2"]
        TARDBP__TDP_43__aggregati["TARDBP (TDP-43) aggregation"] -->|disrupts| GBA_intron_retention_clea["GBA intron retention clearance"]
        FMR1__FMRP_["FMR1 (FMRP)"] -->|regulates translat| GBA_mRNA["GBA mRNA"]
        ELAVL1__HuR_["ELAVL1 (HuR)"] -->|stabilizes| GBA_mRNA_5["GBA mRNA"]
        SCARB2__LIMP_2_["SCARB2 (LIMP-2)"] -->|lysosomal traffick| GBA_protein["GBA protein"]
        EIF2AK3__PERK_["EIF2AK3 (PERK)"] -->|phosphorylates| EIF2S1__eIF2__["EIF2S1 (eIF2α)"]
        EIF2S1__eIF2___phosphoryl["EIF2S1 (eIF2α) phosphorylation"] -.->|suppresses| Cap_dependent_translation["Cap-dependent translation"]
        SRP54["SRP54"] -->|recognizes for ER| GBA_signal_peptide["GBA signal peptide"]
        style GBA_intron_retained_trans fill:#4fc3f7,stroke:#333,color:#000
        style U2AF2 fill:#4fc3f7,stroke:#333,color:#000
        style GBA_intron_retained_trans_1 fill:#4fc3f7,stroke:#333,color:#000
        style SF3B1 fill:#4fc3f7,stroke:#333,color:#000
        style GBA_intron_retained_trans_2 fill:#4fc3f7,stroke:#333,color:#000
        style PRPF8 fill:#4fc3f7,stroke:#333,color:#000
        style GBA_intron_retained_trans_3 fill:#4fc3f7,stroke:#333,color:#000
        style ZNF598 fill:#4fc3f7,stroke:#333,color:#000
        style GBA_intron_retained_trans_4 fill:#4fc3f7,stroke:#333,color:#000
        style GIGYF2 fill:#4fc3f7,stroke:#333,color:#000
        style TARDBP__TDP_43__aggregati fill:#4fc3f7,stroke:#333,color:#000
        style GBA_intron_retention_clea fill:#4fc3f7,stroke:#333,color:#000
        style FMR1__FMRP_ fill:#4fc3f7,stroke:#333,color:#000
        style GBA_mRNA fill:#4fc3f7,stroke:#333,color:#000
        style ELAVL1__HuR_ fill:#4fc3f7,stroke:#333,color:#000
        style GBA_mRNA_5 fill:#4fc3f7,stroke:#333,color:#000
        style SCARB2__LIMP_2_ fill:#4fc3f7,stroke:#333,color:#000
        style GBA_protein fill:#4fc3f7,stroke:#333,color:#000
        style EIF2AK3__PERK_ fill:#4fc3f7,stroke:#333,color:#000
        style EIF2S1__eIF2__ fill:#4fc3f7,stroke:#333,color:#000
        style EIF2S1__eIF2___phosphoryl fill:#4fc3f7,stroke:#333,color:#000
        style Cap_dependent_translation fill:#4fc3f7,stroke:#333,color:#000
        style SRP54 fill:#4fc3f7,stroke:#333,color:#000
        style GBA_signal_peptide fill:#4fc3f7,stroke:#333,color:#000

    3D Protein Structure

    🧬 DICER1 — Search for structure Click to search RCSB PDB
    🔍 Searching RCSB PDB for DICER1 structures...
    Querying Protein Data Bank API

    Source Analysis

    How does the intron-retained RNA isoform mechanistically reduce glucocerebrosidase protein levels and activity?

    neurodegeneration | 2026-04-26 | completed

    Community Feedback

    0 0 upvotes · 0 downvotes
    💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

    No comments yet. Be the first to comment!

    View all feedback (JSON)

    Same Analysis (5)

    Dominant-Negative Spliceosome Titration
    Score: 0.62 · U2AF2, SF3B1, PRPF8; splicing snRNPs
    RNA-Binding Protein Sequestration and 3′UTR Dysregulation
    Score: 0.60 · ELAVL1 (HuR), FMR1 (FMRP), TARDBP (TDP-43); GW182 (TNRC6A)
    Ribosome Stalling and Collision-Induced Translational Repression
    Score: 0.60 · GBA mRNA; ZNF598, GIGYF2, RQC components
    Co-translational ER Targeting Defect and Lysosomal Delivery Failure
    Score: 0.52 · SRP54, SRP68, SRP72 (SRP components); SCARB2 (LIMP-2)
    ER-Associated Degradation (ERAD) Cross-Activation
    Score: 0.52 · EIF2AK3 (PERK), EIF2S1 (eIF2α); HSPA5 (BiP), XBP1
    → View all analysis hypotheses